2013 annual financial data
Eloxx Pharmaceuticals 2013 Operating margin
Direct answer
Operating margin was -4,586.29%.
Operating income was -4,586,290 USD and net income was -6,122,542 USD.
Operating cash flow was -3,902,626 USD.
Get free Eloxx Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 100,000 USD
- Operating income
- -4,586,290 USD
- Net income
- -6,122,542 USD
- Operating cash flow
- -3,902,626 USD